Cellular Therapy Laboratory Research 

The following clinical studies have been possible at Mount Sinai because of the Stem Cell Laboratory’s active participation:

  • Use of expanded cord products for transplantation
  • Use of mesenchymal precursor cells on myocardial function in LVAD bridge to transplant patients
  • Use of autologous CD34+ positive cells for improved symptomatic relief and ischemic wound healing in patients with critical limb ischemia
  • Intravenous infusion of human placenta-derived cells for the treatment of adults with multiple sclerosis
  • Intravenous infusion of human placenta-derived cells for the treatment of adults with Crohn’s disease 

Investigators are encouraged to contact Ding Wen Wu, MD, PhD, Associate Director of Transfusion Medicine / Cellular Therapy, or Yelena Sinitsyn, Supervisor of the Cellular Therapy Lab, during the grant-writing process to seek advice on the most appropriate stem cell processing and storage protocols.